Cargando…
Management of Idiopathic Pulmonary Fibrosis
Objective: Provide information for pharmacists on idiopathic pulmonary fibrosis (IPF) and its treatment. Study Selection and Data Extraction: All articles with data from randomized controlled trials of nintedanib or pirfenidone were reviewed. Data Synthesis: IPF is a progressive and ultimately fatal...
Autores principales: | Pleasants, Roy, Tighe, Robert M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745766/ https://www.ncbi.nlm.nih.gov/pubmed/31280590 http://dx.doi.org/10.1177/1060028019862497 |
Ejemplares similares
-
The Eyes Have It—for Idiopathic Pulmonary Fibrosis: a Preliminary Observation
por: Pleasants, Roy A., et al.
Publicado: (2022) -
Uncovering the Epidemiology of Idiopathic Pulmonary Fibrosis in the Veterans Affairs Health System
por: Tighe, Robert M., et al.
Publicado: (2022) -
Managing comorbidities in idiopathic pulmonary fibrosis
por: Fulton, Blair G, et al.
Publicado: (2015) -
Idiopathic pulmonary fibrosis: pathogenesis and management
por: Sgalla, Giacomo, et al.
Publicado: (2018) -
Advances in the management of idiopathic pulmonary fibrosis
por: Ryu, Jay H, et al.
Publicado: (2010)